Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;16(1):1198.
doi: 10.1007/s12672-025-03042-9.

Research trends and visualization analysis of autoimmune disease-related liver cancer from 2004 to 2024: a bibliometric study

Affiliations

Research trends and visualization analysis of autoimmune disease-related liver cancer from 2004 to 2024: a bibliometric study

Xusheng Zhang et al. Discov Oncol. .

Abstract

Background: Despite the rapid increase in scientific research output related to autoimmune disease-associated liver cancer (ADRLC) in recent years, there is currently a lack of a comprehensive and objective grasp of the cutting-edge progress and future research directions in this research field.

Methods: A comprehensive bibliometric analysis of ADRLC literature was conducted using Biblioshiny, VOSviewer, Scimago Graphica, CiteSpace, and Microsoft Office Excel (Version 2022). Data were extracted from the Web of Science Core Collection (2004-2024).

Results: A total of 1,672 ADRLC papers published from 2004 to 2024 were included. The number of global publications increased steadily, peaking in 2023. The United States had the most publications and citations, followed closely by China and Japan. The WORLD JOURNAL OF GASTROENTEROLOGY published the most articles. High-frequency keywords included "hepatocellular carcinom", "cancer", and "disease" six major research clusters were identified, with "natural history" having the strongest burst impact from 2004 to 2024. Recent trends included "immunotherapy" and "cancer" (2021-2024). Cutting-edge research directions were "immunotherapy" and "immune checkpoint inhibitors".

Conclusion: This study reveals the research directions and trends of ADRLC. The research on ADRLC is increasing globally, with significant contributions from China and the United States. Strengthening research on pathogenesis, early prevention, and individualized treatment of ADRLC is needed. Immunotherapy shows great potential in treating ADRLC and has become a current research hotspot.

Keywords: Autoimmune diseases; Bibliometrics; Immune checkpoint inhibitors; Immunotherapy; Liver cancer.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics and consent to Participate: Not applicable. Consent to publish: All authors agree to the publication of this article. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Diagram of the pathogenic mechanism of liver cancer
Fig. 2
Fig. 2
Flowchart of the study
Fig. 3
Fig. 3
Trends in the annual output of publications and average citation quantity of ADRLC. A Annual publication output related to the ADRLC topic; B Line graph of annual citation counts
Fig. 4
Fig. 4
Country/region analysis. A Collaboration network of countries/regions involved in the research; B Count of publications from each country; C The yearly publication patterns of countries/ regions; D The ranking of countries with the highest citation counts; E Global map of international collaborations; F Distribution of co-authors by country
Fig. 5
Fig. 5
Institutional analysis. A Co-authorship map of institutions participating in the research; B Core institutions ranked by the number of publications; C Publication trend of institutions in the past two decades; D Institution citation association graph
Fig. 6
Fig. 6
Author and co-author analysis. A Co-authorship network diagram; B Author introduction volume correlation diagram from 2014 to 2020; C Author output timeline diagram; D Top 10 authors with the most published literature in the ADRLC field; E Comparison table of author citation counts; F Author local influence
Fig. 7
Fig. 7
Distribution of journals. A Distribution of the number of core journal articles; B Annual distribution of journal articles from 2004 to 2024; C Comparative analysis table of journal H-indexes; D Graph of the interrelationships among journals; E Top ten journals ranked by citation count; F The top twelve journals with the fastest citation growth from 2015 to 2024
Fig. 8
Fig. 8
Co-citation analysis of documents and references. A The top 10 most frequently locally cited documents; B The top 10 most frequently locally referenced documents; C The author-document association matrix of cited references; D The top 15 references with the highest citation burst intensity
Fig. 9
Fig. 9
Keyword analysis and research trends. A The most frequently occurring keywords; B The frequency trend of keywords over time; C The cluster analysis diagram of keywords; D The top 15 keywords with the strongest citation burst force
Fig. 10
Fig. 10
Thematic evolution and trend analysis. A The phased evolution process of ADRLC research topics; B The first appearance time and duration of different keywords

Similar articles

References

    1. Zhang X, Yang L, Liu S, Cao LL, Wang N, Li HC, Ji JF. [Interpretation on the report of global cancer statistics 2022]. Zhonghua Zhong Liu Za Zhi. 2024;46(7):710–21. - PubMed
    1. Xia C, Liu Y, Qing X. Burden of Gastrointestinal cancers in asia, 1990–2019. BMC Gastroenterol. 2025;25(1):232. - PMC - PubMed
    1. Pinheiro PS, Zhang J, Setiawan VW, Cranford HM, Wong RJ, Liu L. Liver Cancer etiology in Asian subgroups and American indian, black, latino, and white populations. Jama Netw Open. 2025;8(3):e252208. - PMC - PubMed
    1. Li YK, Wu S, Wu YS, Zhang WH, Wang Y, Li YH, Kang Q, Huang SQ, Zheng K, Jiang GM, et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: a retrospective study. J Hepatocell Carcino. 2024;11:1389–402. - PMC - PubMed
    1. Bress K, Bou-Samra P, Kallem CJ, Tsung A, Gammer E, Geller DA, Marsh JW, Steel JL. Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90. J Egypt Natl Cancer. 2025;37(1):11. - PMC - PubMed

LinkOut - more resources